HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorUniversity of California, San Francisco

About this trial

The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.

Eligibility criteria

Qualifiers

Patient has received a liver transplant >1 year ago

Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.

Patient has an unmet social risk (e.g., food insecurity) or MLVI >/= 2.0.

Patient will be transferred to adult transplant team in <6 months.

Disqualifiers

Patient has significant cognitive impairment.

Does not meet age criteria

Patient is a ward of the state.

Non-English, non-Spanish speakers.

Trial design

Treatments tested in this trial

  • Health Advocate

Treatment groups

20 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

American Society of Transplantation

Collaborator